Chevy Chase Trust’s Avanos Medical AVNS Stock Holding History

Chevy Chase Trust’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-530	Closed	-$18K	–	656
2019 Q4	$18K	Buy	+530	New	+$19.2K	﹤0.01%	1007

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Chevy Chase Trust's AVNS Position: Q1 2020 in Review

Chevy Chase Trust sold out of Avanos Medical (AVNS) in Q1 2020, closing a stake of 530 shares — an estimated $18K sold.

Chevy Chase Trust first reported a position in AVNS in Q4 2019 and held it in 1 quarter. The position peaked at $18K in Q4 2019. 272 funds tracked by Wall St. Rank hold AVNS as of Q1 2020.

Chevy Chase Trust reported no remaining Avanos Medical position as of Q1 2020 after selling out during the quarter.
Chevy Chase Trust sold 530 Avanos Medical shares in Q1 2020, an estimated $18K.
Chevy Chase Trust first reported a position in Avanos Medical in Q4 2019 and held it in 1 quarter.
Chevy Chase Trust's Avanos Medical position peaked at $18K in Q4 2019.
272 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2020.

Based on Chevy Chase Trust's 13F filing for Q1 2020, filed 13 May 2020.